Renschler, Markus F.
Celgene (United States)
2 papers on CoChat
Most cited papers
- Verified
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine
Pancreatic and Hepatic Oncology ResearchCancer Treatment and Pharmacology
Cited by 6,712
- Verified
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer
Socinski, M. A., Langer, C. J., Okamoto, I., Hon, J. K., Hirsh, V., Dakhil, S. R., Page, R. D., Orsini, J., Zhang, H., & Renschler, M. F. (2013) · Annals of Oncology
Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations
Cited by 108
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free